CRLF2 and acute lymphoblastic leukemia: Recent evidence suggests that specific trisomies in HHD may ameliorate CRLF2-associated relapse risk [11,12]. A previous study with a small sample size showed that patients with Ph-like ALL had similar outcomes to those without Ph-like features when treatment was guided by minimal residual disease (MRD) status [13].